J. Erik Johnson

1.2k total citations
18 papers, 897 citations indexed

About

J. Erik Johnson is a scholar working on Epidemiology, Infectious Diseases and Genetics. According to data from OpenAlex, J. Erik Johnson has authored 18 papers receiving a total of 897 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 8 papers in Infectious Diseases and 8 papers in Genetics. Recurrent topics in J. Erik Johnson's work include Virology and Viral Diseases (11 papers), Virus-based gene therapy research (8 papers) and HIV Research and Treatment (7 papers). J. Erik Johnson is often cited by papers focused on Virology and Viral Diseases (11 papers), Virus-based gene therapy research (8 papers) and HIV Research and Treatment (7 papers). J. Erik Johnson collaborates with scholars based in United States, Nigeria and Canada. J. Erik Johnson's co-authors include John K. Rose, Linda Buonocore, Matthias J. Schnell, David K. Clarke, Stephen A. Udem, R. Michael Hendry, Farooq Nasar, J K Rose, Margaret Lee and John W. Coleman and has published in prestigious journals such as Cell, Journal of Virology and Virology.

In The Last Decade

J. Erik Johnson

18 papers receiving 857 citations

Peers

J. Erik Johnson
J. Norman Flynn United Kingdom
Joanne Higgins United States
Harold Legg United States
Andrew C. Hickey United States
John Hackett United States
Mian‐er Cong United States
J. Norman Flynn United Kingdom
J. Erik Johnson
Citations per year, relative to J. Erik Johnson J. Erik Johnson (= 1×) peers J. Norman Flynn

Countries citing papers authored by J. Erik Johnson

Since Specialization
Citations

This map shows the geographic impact of J. Erik Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Erik Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Erik Johnson more than expected).

Fields of papers citing papers by J. Erik Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Erik Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Erik Johnson. The network helps show where J. Erik Johnson may publish in the future.

Co-authorship network of co-authors of J. Erik Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of J. Erik Johnson. A scholar is included among the top collaborators of J. Erik Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Erik Johnson. J. Erik Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Mathews, Antony J., Ping Cai, Eun Hee Koh, et al.. (2016). Production and Characterization of Chemically Inactivated Genetically Engineered Clostridium difficile Toxoids. Journal of Pharmaceutical Sciences. 105(7). 2032–2041. 15 indexed citations
2.
Akolo, Christopher, Walter Royal, Mariana Cherner, et al.. (2014). Neurocognitive impairment associated with predominantly early stage HIV infection in Abuja, Nigeria. Journal of NeuroVirology. 20(4). 380–387. 32 indexed citations
3.
Johnson, J. Erik, Lisa K. McNeil, Shakuntala Megati, et al.. (2012). Non-propagating, recombinant vesicular stomatitis virus vectors encoding respiratory syncytial virus proteins generate potent humoral and cellular immunity against RSV and are protective in mice. Immunology Letters. 150(1-2). 134–144. 14 indexed citations
4.
Royal, Walter, Mariana Cherner, Jean K. Carr, et al.. (2012). Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria. Journal of NeuroVirology. 18(3). 191–199. 36 indexed citations
5.
Johnson, J. Erik, John W. Coleman, Narender K. Kalyan, et al.. (2009). In vivo biodistribution of a highly attenuated recombinant vesicular stomatitis virus expressing HIV-1 Gag following intramuscular, intranasal, or intravenous inoculation. Vaccine. 27(22). 2930–2939. 21 indexed citations
6.
Witko, Susan E., J. Erik Johnson, Narender K. Kalyan, et al.. (2009). Refined methods for propagating vesicular stomatitis virus vectors that are defective for G protein expression. Journal of Virological Methods. 164(1-2). 43–50. 4 indexed citations
7.
Coleman, John W., J. Erik Johnson, Farooq Nasar, et al.. (2007). Quantitative multiplex assay for simultaneous detection of the Indiana serotype of vesicular stomatitis virus and HIV gag. Journal of Virological Methods. 143(1). 55–64. 9 indexed citations
8.
Coleman, John W., J. Erik Johnson, & David K. Clarke. (2007). Simultaneous Quantification of Four RNA Targets by Multiplex, Real-Time RT-PCR without Optimization. BioTechniques. 43(3). 369–371. 2 indexed citations
10.
Witko, Susan E., J. Erik Johnson, Krista Melville, et al.. (2006). An efficient helper-virus-free method for rescue of recombinant paramyxoviruses and rhadoviruses from a cell line suitable for vaccine development. Journal of Virological Methods. 135(1). 91–101. 53 indexed citations
11.
Johnson, J. Erik, Farooq Nasar, John W. Coleman, et al.. (2006). Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates. Virology. 360(1). 36–49. 127 indexed citations
12.
Clarke, David K., Farooq Nasar, Margaret Lee, et al.. (2006). Synergistic Attenuation of Vesicular Stomatitis Virus by Combination of Specific G Gene Truncations and N Gene Translocations. Journal of Virology. 81(4). 2056–2064. 73 indexed citations
13.
Clarke, David K., M. S. Sidhu, J. Erik Johnson, & Stephen A. Udem. (2000). Rescue of Mumps Virus from cDNA. Journal of Virology. 74(10). 4831–4838. 50 indexed citations
14.
Boritz, Eli, J Gerlach, J. Erik Johnson, & John K. Rose. (1999). Replication-Competent Rhabdoviruses with Human Immunodeficiency Virus Type 1 Coats and Green Fluorescent Protein: Entry by a pH-Independent Pathway. Journal of Virology. 73(8). 6937–6945. 64 indexed citations
16.
Schnell, Matthias J., J. Erik Johnson, Linda Buonocore, & John K. Rose. (1997). Construction of a Novel Virus That Targets HIV-1-Infected Cells and Controls HIV-1 Infection. Cell. 90(5). 849–857. 186 indexed citations
17.
Johnson, J. Erik, Matthias J. Schnell, Linda Buonocore, & J K Rose. (1997). Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins. Journal of Virology. 71(7). 5060–5068. 95 indexed citations
18.
Johnson, J. Erik, et al.. (1996). Replication of Primary HIV-1 Isolates Is Inhibited in PM1 Cells Expressing sCD4-KDEL. Virology. 226(2). 424–429. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026